Dicer ablation promotes a mesenchymal and invasive phenotype in bladder cancer cells

By Lombard Alan P.   Lim Rebecca M.   Nakagawa Rachel M.   Vidallo Kathleen D.   Libertini Stephen J.   Platero Alexander J.   Mudryj Maria  

Oncology Reports, Vol. 34, Iss. 3, 2015-09 ,pp. : 1526-1532

Spandidos Publications

Access to resources Recommend Favorite

Mesenchymal phenotype after chemotherapy is associated with chemoresistance and poor clinical outcome in esophageal cancer

By                    

Oncology Reports, Vol. 31, Iss. 2, 2014-01 ,pp. : 589-596

Spandidos Publications

Access to resources Recommend Favorite

Is there a genomic basis for primary chemoresistance in ovarian cancer?

By Annunziata C.M.   Kohn E.C.  

Gynecologic Oncology, Vol. 90, Iss. 1, 2003-07 ,pp. : 1-2

Elsevier

Access to resources Recommend Favorite

Chemoresistance is associated with Beclin-1 and PTEN expression in epithelial ovarian cancers

By              

Oncology Letters, Vol. 9, Iss. 4, 2015-01 ,pp. : 1759-1763

Spandidos Publications

Access to resources Recommend Favorite

Loss of Dicer expression is associated with breast cancer progression and recurrence

By Khoshnaw Sarkawt  

Breast Cancer Research and Treatment, Vol. 135, Iss. 2, 2012-09 ,pp. : 403-413

Springer Publishing Company

Access to resources Recommend Favorite